• Saint Martin MJ, Orlhac F, Akl P, Khalid F, Nioche C, Buvat I, Malhaire C, Frouin F. A radiomics pipeline dedicated to Breast MRI: validation on a multi-scanner phantom study. MAGMA. 2020. in press. 
  • Weber WA, Czernin J, Anderson CJ, Badawi RD, Bartel H, Bengel F, Bodei L, Buvat I, DiCarli M, Graham MM, Grimm J, Herrmann K, Kostakoglu L, Lewis JS, Peterson T, Schelbert H, Schoder H, Siegel BA, Strauss HW, Townsend DM. The future of nuclear medicine, molecular imaging, and theranostics. J Nucl Med. 2020. in press. 

  • Sundar LKS , Muzik O, Buvat I, Bidaut L, Beyer T. Potentials and caveats of artificial intelligence in hybrid imaging. Methods. 2020. in press. DOI: 10.1016/j.ymeth.2020.10.004

  • Orlhac F, Lecler A, Savatovski J, Goya-Outi J, Nioche C, Charbonneau F, Ayache N, Frouin F, Duron L, Buvat I. How can we combat multicenter variability in MR radiomics? Validation of a correction procedure. Eur Rad. 2020. in press. DOI: 10.1007/s00330-020-07284-9
  • Lamirault C, Doyère V, Juchaux M, Pouzoulet F, Labiod D, Dendale R, Patriarca A, Nauraye C, Le Dudal M, Jouvion G, Hardy D, Massioui NE, Prezado Y. Short and long term evaluation of the impact of proton mini beam radiation therapy on motor, emotional and cognitive functions. Sci Rep. 10:13511, 2020. DOI: 10.1038/s41598-020-70371-w

  • Capobianco N, Meignan M, Cottereau AS, Vercellino L, Sibille L, Spottiswoode B, Zuehlsdorff S, Casasnovas O, Thieblemont C, Buvat I. Deep learning FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma. J Nucl Med. 2020. in press. DOI: 10.2967/jnumed.120.242412
  • Wimberley C, Nguyen DL, Truillet C, Peyronneau MA, Gulhan Z, Tonietto M, Boumezbeur F, Boisgard R, Chalon S, Bouilleret V, Buvat ILongitudinal mouse-PET imaging: a reliable method for estimating binding parameters without a reference region or blood sampling. Eur J Nucl Med Mol Imaging. 2020. in press. DOI: 10.1007/s00259-020-04755-5

  • Zwanenburg A, Vallières M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, Ashrafinia S, Bakas S, Beukinga RJ, Boellaard R, Bogowicz M, Boldrini L, Buvat I, Cook GJR, Davatzikos C, Depeursinge A, Desseroit MC, Dinapoli N, Dinh CV, Echegaray V, El Naqa I, Fedorov AY, Gatta R, Gillies RJ, Goh V, Guckenberger M, Götz M, Ha SM, Hatt M, Isensee F, Lambin P, Leger S, Leijenaar RTH, Lenkowicz J, Lippert F, Losnegård A, Maier-Hein KH, Morin O, Müller H, Napel S, Nioche COrlhac F, Pati S, Pfaehler EAG, Rahmim A, Rao AUK, Scherer J, Siddique MM, Sijtsema NM, Fernandez JS, Spezi E, Steenbakkers RJHM, Tanadini-Lang S, Thorwarth D, Troost EGC, Upadhaya T, Valentini C, van Dijk LV, van Griethuysen J, van Velden FHP, Whybra P, Richter C, Löck S. The Image Biomarker Standardization Initiative: standardized quantitative radiomics for highthroughput image-based phenotyping. Radiology. 295:328-338, 2020. DOI: 10.1148/radiol.2020191145

  • Lemaître S, Poyer F, Fréneaux P, Leboucher S, Doz F, Cassoux N, Thomas CD. Low retinal toxicity of intravitreal carboplatin associated with good retinal tumour control in transgenic murine retinoblastoma. Clin Exp Ophthalmol. 48:500-511, 2020. DOI: 10.1111/ceo.13711
  • Tanaka I, Chakraborty A, Saulnier O, Benoit-Pilven C, Vacher S, Labiod D, Lam EWF, Bièche I, Delattre O, Pouzoulet F, Auboeuf D, Vagner S, Dutertre M. ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin. Nucleic Acids Res. 2020. DOI: 10.1093/nar/gkz1213

  • Lacroix M, Frouin F, Dirand AS, Nioche C, Orlhac F, Bernaudin JF, Brillet PY, Buvat I. Correction for magnetic field inhomogeneities and normalization of voxel values are needed to better reveal the potential of MR radiomic features in lung cancer. Front Oncol. doi: 10.3389/fonc.2020.00043, 2020. DOI: 10.3389/fonc.2020.00043

  • Cottereau AS, Nioche C, Dirand AS, Clerc J, Morschhauser F, Casasnovas O, Meignan MA, Buvat I. 18F-FDG-PET dissemination features in diffuse large B cell lymphoma are predictive of outcome. J Nucl Med. 61. 40-45, 2020. DOI: 10.2967/jnumed.119.229450

  • Provost C, Mammar H, Belly-Poinsignon A, Madar O, Champion L. Pharmacokinetic Analysis of [18F]FAZA Dynamic PET Imaging Acquisitions for Highlighting Sacrum Tumor Profiles. Clin Nucl Med. 45:e36-e38, 2020. DOI: 10.1097/RLU.0000000000002813